双能CT肺动脉造影定量评估重型COVID-19肺炎血管病变
本研究回顾性纳入27例接受机械通气的重型COVID-19肺炎患者,行双能CT肺动脉造影(DECTPA)灌注血容量(PBV)图分析,其中11例在14±11.6天后复查。结果显示灌注缺损以无定形为主(21例),PBV/PAenh(18.2±4.2%)低于健康志愿者(27±13.9%,p=0.002),且与病程相关(β=0.13,p=0.04)、与右心室功能障碍负相关(β=-7.2,p=0.001)。
要点
- 重型COVID-19肺炎DECTPA常见无定形灌注缺损(21/27),仅楔形缺损与肺血栓对应(2/27)。
- PBV/PAenh较健康志愿者降低(18.2±4.2% vs 27±13.9%,p=0.002),或可提示血管病变。
- PBV/PAenh与病程正相关(β=0.13,p=0.04)、与右心室功能障碍负相关(β=-7.2,p=0.001)。
关键影像表现/征象
- 灌注缺损模式包括无定形(n=21)、斑驳状(n=4)和楔形(n=2),平均灌注缺损范围36.1%±17.2%。
- 急性肺血栓见于11/27(40.7%)患者,仅楔形缺损与肺血栓对应(2/27,7.4%)。
- 平均CT阻塞指数为2.6±5.4(总分40)。
- PBV/PAenh为18.2±4.2%,低于健康志愿者的27±13.9%(p=0.002)。
诊断标准与关键数值
- 灌注缺损模式定性分为楔形、斑驳状或无定形。
- PBV/PAenh为灌注血容量相对于肺动脉强化的比值,患者为18.2±4.2%,健康志愿者为27±13.9%(p=0.002)。
- PBV/PAenh与病程相关(β=0.13,p=0.04),与右心室功能障碍负相关(β=-7.2,p=0.001)。
- PBV/PAenh与D-二聚体或CT阻塞指数之间无关联。
临床应用与阅片要点
- 阅读DECTPA时注意识别灌注缺损模式,无定形和斑驳状缺损不一定代表肺血栓。
- 楔形灌注缺损需警惕肺血栓,本研究中仅楔形缺损与血栓对应。
- PBV/PAenh降低可能反映血管病变,即使无动脉血栓也应关注。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The role of dual energy computed tomographic pulmonary angiography (DECTPA) in revealing vasculopathy in coronavirus disease 2019 (COVID-19) has not been fully explored.
PURPOSE: To evaluate the relationship between DECTPA and disease duration, right ventricular dysfunction (RVD), lung compliance, D-dimer and obstruction index in COVID-19 pneumonia.
MATERIALS AND METHODS: This institutional review board approved this retrospective study, and waived the informed consent requirement. Between March-May 2020, 27 consecutive ventilated patients with severe COVID-19 pneumonia underwent DECTPA to diagnose pulmonary thrombus (PT); 11 underwent surveillance DECTPA 14 ±11.6 days later. Qualitative and quantitative analysis of perfused blood volume (PBV) maps recorded: i) perfusion defect 'pattern' (wedge-shaped, mottled or amorphous), ii) presence of PT and CT obstruction index (CTOI) and iii) PBV relative to pulmonary artery enhancement (PBV/PAenh); PBV/PAenh was also compared with seven healthy volunteers and correlated with D-Dimer and CTOI.
RESULTS: Amorphous (n=21), mottled (n=4), and wedge-shaped (n=2) perfusion defects were observed (M=20; mean age=56 ±8.7 years). Mean extent of perfusion defects=36.1%±17.2. Acute PT was present in 11/27(40.7%) patients. Only wedge-shaped defects corresponded with PT (2/27, 7.4%). Mean CTOI was 2.6±5.4 out of 40. PBV/PAenh (18.2 ±4.2%) was lower than in healthy volunteers (27 ±13.9%, p = 0.002). PBV/PAenh correlated with disease duration (β = 0.13, p = 0.04), and inversely correlated with RVD (β = -7.2, p = 0.001), persisting after controlling for confounders. There were no linkages between PBV/PAenh and D-dimer or CTOI.
CONCLUSION: Perfusion defects and decreased PBV/PAenh are prevalent in severe COVID-19 pneumonia. PBV/PAenh correlates with disease duration and inversely correlates with RVD. PBV/PAenh may be an important marker of vasculopathy in severe COVID-19 pneumonia even in the absence of arterial thrombus.
引用
- Ridge CA, Desai SR, Jeyin N, et al. Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia. Radiol Cardiothorac Imaging. 2020. PMID: 33778632. doi:10.1148/ryct.2020200428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。